17:14 EDT vTv Therapeutics files $250M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTVT:
- vTv Therapeutics Appoints Anne Phillips, Reshuffles Board Committees
- vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
- vTv Therapeutics expects cash to fund operations through Phase 3 study data
- vTv Therapeutics reports Q4 EPS ($1.67) vs. ($2.28) last year
- vTv Therapeutics Enhances Investor Communication with Update
